Women at heart: Introducing gender cardio-oncology.
anthracyclines
cardio-oncology
gender medicine
immunotherapy
radiotherapy
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
06
2022
accepted:
25
10
2022
entrez:
12
12
2022
pubmed:
13
12
2022
medline:
13
12
2022
Statut:
epublish
Résumé
As cardio-oncology imposed itself as the reference specialty for a comprehensive cardiovascular approach to all patients with cancer, a more specific and careful cardiac evaluation of women entering their journey into cancer care is needed. Gender medicine refers to the study of how sex-based biological and gender-based socioeconomic and cultural differences influence people's health. Gender-related aspects could account for differences in the development, progression, and clinical signs of diseases as well as in the treatment of adverse events. Gender also accounts for major differences in access to healthcare. As for medicine and healthcare in general, gender-related characteristics have gained significance in cardio-oncology and should no longer be neglected in both clinical practice and research. We aimed to review the most relevant cardiovascular issues in women related to the cardio-oncology approach to offer a specific gender-related point of view for clinicians involved in the care process for both cancer and cardiovascular disease.
Identifiants
pubmed: 36505385
doi: 10.3389/fcvm.2022.974123
pmc: PMC9726754
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
974123Informations de copyright
Copyright © 2022 Canale, Bisceglia, Gallucci, Russo, Camerini, Di Fusco, Paccone, Camilli, Fiscella, Lestuzzi, Turazza, Gulizia, Pavan, Maurea, Gabrielli, Oliva and Colivicchi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Cardiovasc Pharmacol Ther. 2021 Mar;26(2):103-113
pubmed: 33124480
Toxicol Appl Pharmacol. 2016 Nov 1;310:159-174
pubmed: 27644598
Prim Care. 2018 Mar;45(1):131-141
pubmed: 29406939
Cancers (Basel). 2019 Oct 28;11(11):
pubmed: 31661803
Cancers (Basel). 2021 Jan 23;13(3):
pubmed: 33498754
Phenomics. 2022;2(3):184-193
pubmed: 35578620
J Natl Cancer Inst. 2021 Oct 1;113(10):1396-1404
pubmed: 33705549
Circ Res. 2010 Jun 11;106(11):1681-91
pubmed: 20413785
Cardiovasc Radiat Med. 1999 Jan-Mar;1(1):98-101
pubmed: 11272363
Blood. 2010 Sep 30;116(13):2237-40
pubmed: 20595518
Ann Oncol. 2013 Oct;24 Suppl 6:vi160-70
pubmed: 23813932
Circ J. 2014;78(9):2119-28
pubmed: 25099475
J Clin Oncol. 2016 Apr 1;34(10):1122-30
pubmed: 26834065
Eur J Cancer. 2006 Oct;42(15):2549-53
pubmed: 16919450
Cancer. 2009 Nov 15;115(22):5296-308
pubmed: 19672997
JAMA. 1996 May 22-29;275(20):1557-62
pubmed: 8622246
Nat Rev Cardiol. 2020 Aug;17(8):474-502
pubmed: 32231332
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Nat Rev Cardiol. 2011 Jan;8(1):30-41
pubmed: 21060326
Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):e333-e465
pubmed: 36017575
Am J Med. 1981 Mar;70(3):519-30
pubmed: 6782873
Heart. 2008 Mar;94(3):264-5
pubmed: 18276810
Lancet. 2012 Feb 11;379(9815):570-9
pubmed: 22325662
Cardiooncology. 2020 Aug 05;6:12
pubmed: 32774890
N Engl J Med. 2015 Nov 5;373(19):1824-34
pubmed: 26415085
Nature. 2011 Feb 17;470(7334):359-65
pubmed: 21307849
Eur Heart J. 2012 Nov;33(22):2771-2782b
pubmed: 22915165
J Am Coll Cardiol. 2018 Oct 23;72(17):2087-2089
pubmed: 30336834
Circulation. 2015 Dec 22;132(25):2424-47
pubmed: 26644329
J Am Coll Cardiol. 2009 Oct 20;54(17):1561-75
pubmed: 19833255
Cancer. 2019 Jan 15;125(2):307-316
pubmed: 30335191
Lancet. 2011 Oct 8;378(9799):1297-305
pubmed: 21839503
Biol Sex Differ. 2015 Oct 15;6:20
pubmed: 26478810
BMJ. 2009 Dec 08;339:b4606
pubmed: 19996459
Breast Cancer Res Treat. 2010 Dec;124(3):745-53
pubmed: 18704681
J Clin Oncol. 2017 May 20;35(15):1641-1649
pubmed: 28319436
Nat Rev Cancer. 2014 Jan;14(1):61-70
pubmed: 24304873
J Cardiovasc Med (Hagerstown). 2021 Jan;22(1):36-44
pubmed: 32740424
BMC Public Health. 2021 Feb 27;21(1):415
pubmed: 33639910
J Clin Oncol. 2017 Mar 10;35(8):893-911
pubmed: 27918725
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Blood. 2011 Jan 13;117(2):412-8
pubmed: 20858859
Cancers (Basel). 2020 Dec 03;12(12):
pubmed: 33287242
BMC Cancer. 2021 Apr 26;21(1):463
pubmed: 33902516
J Clin Oncol. 2008 Jul 1;26(19):3159-65
pubmed: 18591554
Breast J. 2019 Jan;25(1):86-90
pubmed: 30419602
Lancet Oncol. 2018 Mar;19(3):337-346
pubmed: 29395867
J Clin Oncol. 2005 Dec 1;23(34):8597-605
pubmed: 16314622
Eur Heart J. 2016 Jan 1;37(1):24-34
pubmed: 26530104
Can J Cardiol. 2020 Jan;36(1):37-44
pubmed: 31515085
Can J Cardiol. 2019 May;35(5):653-660
pubmed: 31030866
Cancers (Basel). 2020 May 18;12(5):
pubmed: 32443608
Ann Oncol. 2020 Feb;31(2):171-190
pubmed: 31959335
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
J Clin Oncol. 2006 Jan 20;24(3):467-75
pubmed: 16421423
J Natl Cancer Inst. 2012 Sep 5;104(17):1293-305
pubmed: 22949432
JAMA Oncol. 2021 Jun 01;7(6):924-932
pubmed: 33662107
Circ Res. 2022 Feb 18;130(4):632-651
pubmed: 35175846
J Clin Oncol. 2020 Sep 20;38(27):3161-3174
pubmed: 32673152
Ann Oncol. 2019 Oct 1;30(10):1674
pubmed: 31236598
Ann Oncol. 2020 Jun;31(6):674-696
pubmed: 32199930
Obstet Gynecol Clin North Am. 2005 Dec;32(4):627-40
pubmed: 16310676
JAMA Intern Med. 2015 Jun;175(6):1007-17
pubmed: 25915855
Lancet Oncol. 2004 May;5(5):283-91
pubmed: 15120665
Am Heart J. 2008 Nov;156(5):918-30
pubmed: 19061708
Clin Immunol. 2020 Apr;213:108377
pubmed: 32135278
JACC CardioOncol. 2020 Jun;2(2):340-342
pubmed: 32548595
Radiat Res. 2010 Dec;174(6):865-9
pubmed: 21128810
J Natl Cancer Inst. 2022 Apr 11;114(4):553-564
pubmed: 35043954
Health Qual Life Outcomes. 2019 Apr 18;17(1):69
pubmed: 30999899
JAMA Oncol. 2019 Nov 1;5(11):1635-1637
pubmed: 31436802
J Cancer Surviv. 2016 Feb;10(1):113-21
pubmed: 26044903
Nat Commun. 2019 Feb 8;10(1):666
pubmed: 30737381
Am J Obstet Gynecol. 2003 Sep;189(3):853-7
pubmed: 14526329
Diabetes Care. 2021 Aug 12;:
pubmed: 34385145
J Clin Oncol. 2018 Jul 20;36(21):2135-2144
pubmed: 29874141
Cancers (Basel). 2019 Jul 24;11(8):
pubmed: 31344922
J Clin Oncol. 2012 May 1;30(13):1429-37
pubmed: 22473161
Cardiovasc Res. 2022 Mar 25;118(5):1173-1187
pubmed: 33963378
Cancers (Basel). 2021 Aug 06;13(16):
pubmed: 34439129
Nat Rev Cardiol. 2020 Aug;17(8):503-522
pubmed: 32218531
Cancer. 2003 Jun 1;97(11):2869-79
pubmed: 12767102
J Clin Oncol. 1997 Apr;15(4):1544-52
pubmed: 9193351
Cancer Discov. 2017 Feb;7(2):165-176
pubmed: 27979832
JACC Basic Transl Sci. 2018 Aug 28;3(4):563-572
pubmed: 30175280
Pharmacol Res. 2017 Jun;120:34-42
pubmed: 28300617
Cancer. 2022 Jul 1;128(13):2405-2419
pubmed: 35435238
Front Cardiovasc Med. 2021 Jun 16;8:677544
pubmed: 34222373
J Am Coll Cardiol. 2012 Jan 24;59(4):410-7
pubmed: 22261164
J Am Coll Cardiol. 2020 Jan 21;75(2):207-221
pubmed: 31948651
BMJ. 2020 Jan 15;368:l6794
pubmed: 31941657
JAMA Oncol. 2015 Nov;1(8):1145-53
pubmed: 26247818
Am J Cardiol. 2015 Aug 1;116(3):442-6
pubmed: 26071994
N Engl J Med. 1995 Jun 29;332(26):1738-43
pubmed: 7760889
J Am Coll Cardiol. 2021 Mar 2;77(8):1057-1068
pubmed: 33632480
JACC CardioOncol. 2020 Jun 16;2(2):153-162
pubmed: 34396225
J Clin Oncol. 2007 Sep 1;25(25):3808-15
pubmed: 17664460
ESMO Open. 2017 Dec 18;2(5):e000250
pubmed: 29326844
JAMA Oncol. 2015 Sep;1(6):814-9
pubmed: 26355862
Cardiovasc Res. 2017 Jun 1;113(7):711-724
pubmed: 28472454
Clin Res Cardiol. 2020 Oct;109(10):1197-1222
pubmed: 32405737
J Am Coll Cardiol. 2017 Feb 7;69(5):594-595
pubmed: 28153113
JACC Heart Fail. 2016 Dec;4(12):923-931
pubmed: 27908391
CA Cancer J Clin. 2020 Mar;70(2):86-104
pubmed: 31944278
N Engl J Med. 2006 Jul 20;355(3):251-9
pubmed: 16855265
Oncologist. 2019 Nov;24(11):e1148-e1155
pubmed: 31036771
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
Diabetologia. 2014 Aug;57(8):1542-51
pubmed: 24859435